Skip to main content
Canadian Family Physician logoLink to Canadian Family Physician
. 1989 Oct;35:2095-2098, 2172.

Investigation and Management of Renal Stones

Brendan J Barrett, John D Harnett
PMCID: PMC2280933  PMID: 21249089

Abstract

Renal stones are a major source of morbidity and health care expenditure. Stone-forming patients may be grouped according to the etiological factors of their disease. Investigation begins with an appropriate history and physical examination, followed by selected laboratory tests aimed at discovering factors that may be contributing to stone formation and also at classifying the activity of the stone disease. Management depends on timely surgical procedures to deal with problematic stones and on advice concerning fluid intake, dietary modification, and in some cases, drug therapy to prevent further stone formation.

Keywords: nephrology, renal stones, urolithiasis, urology

Full text

PDF
2095

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chaussy C., Schüller J., Schmiedt E., Brandl H., Jocham D., Liedl B. Extracorporeal shock-wave lithotripsy (ESWL) for treatment of urolithiasis. Urology. 1984 May;23(5 Spec No):59–66. doi: 10.1016/0090-4295(84)90243-7. [DOI] [PubMed] [Google Scholar]
  2. Churchill D. N. Medical treatment to prevent recurrent calcium urolithiasis. A guide to critical appraisal. Miner Electrolyte Metab. 1987;13(4):294–304. [PubMed] [Google Scholar]
  3. Gault M. H., Chafe L., Parfrey P., Robertson W. G. The kidney-ureter stone sexual paradox: a possible explanation. J Urol. 1989 May;141(5):1104–1106. doi: 10.1016/s0022-5347(17)41183-9. [DOI] [PubMed] [Google Scholar]
  4. Gault M. H., Parfrey P. S., Robertson W. G. Idiopathic calcium phosphate nephrolithiasis. Nephron. 1988;48(4):265–273. doi: 10.1159/000184940. [DOI] [PubMed] [Google Scholar]
  5. Johnson C. M., Wilson D. M., O'Fallon W. M., Malek R. S., Kurland L. T. Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int. 1979 Nov;16(5):624–631. doi: 10.1038/ki.1979.173. [DOI] [PubMed] [Google Scholar]
  6. Pak C. Y., Fuller C., Sakhaee K., Preminger G. M., Britton F. Long-term treatment of calcium nephrolithiasis with potassium citrate. J Urol. 1985 Jul;134(1):11–19. doi: 10.1016/s0022-5347(17)46962-x. [DOI] [PubMed] [Google Scholar]
  7. Segura J. W. Endourology. J Urol. 1984 Dec;132(6):1079–1084. doi: 10.1016/s0022-5347(17)50041-5. [DOI] [PubMed] [Google Scholar]
  8. Smith L. H., Werness P. G., Wilson D. M. Metabolic and clinical disturbances in patients with calcium urolithiasis. Scand J Urol Nephrol Suppl. 1980;53:213–220. [PubMed] [Google Scholar]
  9. Strauss A. L., Coe F. L., Deutsch L., Parks J. H. Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. Am J Med. 1982 Jan;72(1):17–24. doi: 10.1016/0002-9343(82)90566-6. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES